doi: 10.1002/oby.21212 16 BruntV
the underlying cellular environment, oxidative stress, mitochondrial function, and detoxification capacity, shapes how you age and how well you respond to every other treatment
Over the past several years GLP-1 receptor agonists have been developed as medications for managing diabetes, cardiovascular disease, and obesity
ERR start improves cellular energy production and reduces body dysfunction
These observations underscore a crucial point: the complications are closely linked to the immune system, and the regeneration of TMI relies heavily on the inflammatory processes during this phase (91)
If you are not losing weight on GLP-1 therapy , thyroid optimization should be the first thing investigated